As research in this direction advanced, TNFα has been identified as a most powerful pro-cancer cytokine in many malignancies, suggesting that inhibitors of TNFα and/or its receptors (TNFR) could be applied in cancer treatment, alone or together with other modes of therapy. The gene discussed is TNF; the disease is cancer.